Zobrazeno 1 - 10
of 533
pro vyhledávání: '"Giulio Marchesini"'
Autor:
Lucia Brodosi, Michele Stecchi, Francesca Marchignoli, Elisabetta Lucia, Lucia Magnani, Valeria Guarneri, Maria Letizia Petroni, Giulio Marchesini, Loris Pironi
Publikováno v:
Eating and Weight Disorders, Vol 28, Iss 1, Pp 1-9 (2023)
Abstract Purpose Very few data exist on the association between metabolic dysfunction-associated steatotic liver disease (MASLD) and eating disorders. The study aimed to evaluate the presence of binge eating disorder (BED), in MASLD subjects. Methods
Externí odkaz:
https://doaj.org/article/3f70fef7612e4c08a5e1966f5b176eb0
Autor:
Federica Perazza, Laura Leoni, Santo Colosimo, Alessandra Musio, Giulia Bocedi, Michela D’Avino, Giulio Agnelli, Alba Nicastri, Chiara Rossetti, Federica Sacilotto, Giulio Marchesini, Maria Letizia Petroni, Federico Ravaioli
Publikováno v:
Metabolites, Vol 14, Iss 4, p 186 (2024)
Metformin is a highly effective medication for managing type 2 diabetes mellitus. Recent studies have shown that it has significant therapeutic benefits in various organ systems, particularly the liver. Although the effects of metformin on metabolic
Externí odkaz:
https://doaj.org/article/1e23f0dfb91c443c91d74ccccb84b803
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus
Autor:
Marta Nugnes, Maurizio Baldassarre, Danilo Ribichini, Daniele Tedesco, Irene Capelli, Daniele Vetrano, Francesca Marchignoli, Lucia Brodosi, Enrico Pompili, Maria Letizia Petroni, Gaetano La Manna, Giulio Marchesini, Marina Naldi, Manuela Bartolini
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 6, p 3168 (2024)
Diabetic kidney disease (DKD) is a major cause of morbidity and mortality in individuals with type 2 diabetes mellitus (T2DM). The aim of this study was to investigate whether albumin structural alterations correlate with DKD severity and evaluate wh
Externí odkaz:
https://doaj.org/article/92877081d64248bbad0bb6dfde7c2dfe
Publikováno v:
Annals of Hepatology, Vol 28, Iss 1, Pp 100772- (2023)
Externí odkaz:
https://doaj.org/article/773eee6947df499e93d07d03fcdb64d7
Autor:
Maria Letizia Petroni, Lucia Brodosi, Angelo Armandi, Francesca Marchignoli, Elisabetta Bugianesi, Giulio Marchesini
Publikováno v:
Nutrients, Vol 15, Iss 3, p 792 (2023)
Background: Behavioral programs are needed for prevention and treatment of NAFLD and the effectiveness of a web-based intervention (WBI) is similar to a standard group-based intervention (GBI) on liver disease biomarkers. Objective: We aimed to test
Externí odkaz:
https://doaj.org/article/98639db6c25a48969fde72e08034514e
Autor:
Claudio Belvedere, Claudia Giacomozzi, Claudio Carrara, Giada Lullini, Paolo Caravaggi, Lisa Berti, Giulio Marchesini, Luca Baccolini, Stefano Durante, Alberto Leardini
Publikováno v:
Journal of Foot and Ankle Research, Vol 13, Iss 1, Pp 1-11 (2020)
Abstract Background Measurements of plantar loading reveal foot-to-floor interaction during activity, but information on bone architecture cannot be derived. Recently, cone-beam computer tomography (CBCT) has given visual access to skeletal structure
Externí odkaz:
https://doaj.org/article/44454bec296d446da06595d4cc142830
Autor:
Andrea Fabbri, Giulio Marchesini, Barbara Benazzi, Alice Morelli, Danilo Montesi, Cesare Bini, Stefano Giovanni Rizzo
Publikováno v:
BMC Geriatrics, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background The burden of sepsis represents a global health care problem. We aimed to assess the case fatality rate (CFR) and its predictors in subjects with sepsis admitted to a general Italian hospital from 2009 to 2016, stratified by risk
Externí odkaz:
https://doaj.org/article/5f2c882925c6451f97e5a68b77e79669
Autor:
Sven M. Francque, Giulio Marchesini, Achim Kautz, Martine Walmsley, Rebecca Dorner, Jeffrey V. Lazarus, Shira Zelber-Sagi, Kate Hallsworth, Luca Busetto, Gema Frühbeck, Dror Dicker, Euan Woodward, Marko Korenjak, José Willemse, Gerardus H. Koek, Shlomo Vinker, Mehmet Ungan, Juan M. Mendive, Christos Lionis
Publikováno v:
JHEP Reports, Vol 3, Iss 5, Pp 100322- (2021)
Summary: This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and comes with a high disease burden. Yet, there is a lot of
Externí odkaz:
https://doaj.org/article/5859980da3ca44949142e0cb780c5d1c
Publikováno v:
Expert Opinion on Pharmacotherapy. :1-12
Autor:
Andrei, Federica, Nuccitelli, Chiara, Mancini, Giacomo, Reggiani, Giulio Marchesini, Trombini, Elena
Publikováno v:
In Psychiatry Research November 2018 269:191-198